Compare Natera Inc. Common Stock (NTRA) vs Pacer Data & Infra Real Estate ETF (SRVR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Pacer Data & Infra Real Estate ETF — how do they compare? Natera Inc. Common Stock trades at $394.6 (market cap $57.03B), while Pacer Data & Infra Real Estate ETF trades at $27.78 (market cap $300.94M). The key difference: Natera Inc. Common Stock is far larger — about 189.5× Pacer Data & Infra Real Estate ETF's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Pacer Data & Infra Real Estate ETF for 16 Days on average.
| NTRA | SRVR | |
|---|---|---|
Market Cap | $57.03B | $300.94M |
Volume | 1,131,157 | 73,849 |
Sector | Health | Sector/Thematic |
52-Week High | $425.64 | $35.74 |
52-Week Low | $179.42 | $27.94 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SRVR trades at $28.62, down 1.31% today, with a mixed technical outlook—bullish overall signal but bearish moving averages. Key financial ratios are unavailable, limiting fundamental assessment. Recent news highlights data center ETFs as a way to gain exposure to AI and cloud computing growth, suggesting thematic relevance.
The outlook is cautiously optimistic due to AI-driven demand for data centers, but risks include reliance on thematic trends and lack of current financial data. Investors should seek updated fundamentals to gauge valuation and growth prospects amid competitive and macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Pacer Data & Infra Real Estate ETF
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →
